Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche – Biotech Investments
Lonza Group AG / Key word(s): Acquisition/Investment 20-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is